Click on each section you wish to purchase
Click on add to cart to add all the sections in shopping cart
Click on the cart to proceed to payment
Click on Checkout to complete the final checkout
Executive Summary
Opium Withdrawal Syndrome Global Clinical Trials Review, H1, 2018
Summary
GlobalData's clinical trial report, "Opium Withdrawal Syndrome Global Clinical Trials Review, H1, 2018" provides an overview of Opium Withdrawal Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Opium Withdrawal Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Opium Withdrawal Syndrome to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Opium Withdrawal Syndrome to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Opium Withdrawal Syndrome Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 60
Abbreviations 60
Definitions 60
Research Methodology 61
Secondary Research 61
About GlobalData 62
Contact Us 62
Source 62
List of Figures
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 9
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Europe, Top Countries (%), 2018* 10
Opium Withdrawal Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 11
Proportion of Opium Withdrawal Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 13
Opium Withdrawal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Opium Withdrawal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Proportion of Opium Withdrawal Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 16
Opium Withdrawal Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 17
Opium Withdrawal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 18
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2018* 19
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 20
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 21
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 22
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 23
Opium Withdrawal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 24
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27
GlobalData Methodology 61
List of Tables
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials by Region, 2018* 6
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 9
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Europe, Top Countries, 2018* 10
Opium Withdrawal Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 12
Proportion of Opium Withdrawal Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 13
Opium Withdrawal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Opium Withdrawal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Proportion of Opium Withdrawal Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 16
Opium Withdrawal Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 17
Opium Withdrawal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 18
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials by Phase, 2018* 19
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 20
Opium Withdrawal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 21
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 22
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 23
Opium Withdrawal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 24
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26
Opium Withdrawal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
US WorldMeds LLC Worldwide Clinical Trials Inc Indivior Plc MediciNova Inc Johns Hopkins HealthCare LLC Insys Therapeutics Inc Hospira (non Resident Limited Co.) Elite Pharmaceuticals Inc DemeRx Inc Altasciences Company Inc
For Regular updates on our latest research reports
Compare
|
|
| Details | |
| Date | |
| January 1970 | January 1970 |
| Pages | |
| Price | |
| USD | USD |
| Companies Covered | |
| Products | |
| Publisher | |
| Discount Offer | |
| - | - |
| Download TOC | Scope | LOF | LOT | |
 |
|
| 
